Triple transplantation of autologous peripheral blood stem cells each time following conditioning with 100 mg/m 2 of melphalan for multiple myeloma patients in poor performance status

Author： Rokicka M.   Urbanowska E.   Torosian T.   Dwilewicz-Trojaczek J.   Awedan A.   Paluszewska M.   Wiktor-Jedrzejczak W.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.35, Iss.6, 2003-09, pp. : 2352-2354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus I.V. melphalan

By Vela-Ojeda J.   García-Ruiz-Esparza M.   Padilla-González Y.   Gómez-Almaguer D.   Gutiérrez-Aguirre C.   Gómez-Rangel D.   Morales-Toquero A.   Ruiz-Delgado G.   Delgado-Lamas J.   Ruiz-Argüelles G.  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 277-282

Springer Publishing Company

Access to resources Recommend Favorite

Transplantation with selected autologous peripheral blood CD34 + Thy1 + hematopoietic stem cells in multiple myeloma - The issue of safety

By Sica S.   Sora F.   Chiusolo P.   Cicconi S.   Piccirillo N.   Cattani P.   Laurenti L.   Leone G.  

Experimental Hematology, Vol. 29, Iss. 1, 2001-01 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

By Hicks C.   Wong R.   Manoharan A.   Kwan Y.  

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 591-598

Springer Publishing Company

Access to resources Recommend Favorite

Transplantation with selected autologous peripheral blood CD34 + Thy1 + hematopoietic stem cells (HSCs) in multiple myeloma - Impact of HSC dose on engraftment, safety, and immune reconstitution

By Michallet M.   Philip T.   Philip I.   Godinot H.   Sebban C.   Salles G.   Thiebaut A.   Biron P.   Lopez F.   Mazars P.   Roubi N.   Leemhuis T.   Hanania E.   Reading C.   Fine G.   Atkinson K.   Juttner C.   Coiffier B.   Fiere D.   Archimbaud  

Experimental Hematology, Vol. 28, Iss. 7, 2000-07 ,pp. : 858-870

Elsevier

Access to resources Recommend Favorite

Evaluation of relative anti-myeloma activity of high-dose melphalan followed by the first peripheral blood stem cell transplantation, as compared with the second transplantation, and to VAD chemotherapy

By Awedan A.   Krol M.   Blajer B.   Rokicka M.   Torosian T.   Urbanowska E.   Wiktor-Jedrzejczak W.  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2349-2351

Elsevier

Access to resources Recommend Favorite